Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.160
-0.060 (-2.70%)
At close: Nov 21, 2024, 4:00 PM
2.170
+0.010 (0.46%)
After-hours: Nov 21, 2024, 5:50 PM EST
Tenaya Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 8.23 | 45.68 | 95.27 | 38.13 | 128.54 | 23.87 |
Short-Term Investments | 71.24 | 58.96 | 91.26 | 213.17 | - | 2.75 |
Cash & Short-Term Investments | 79.47 | 104.64 | 186.53 | 251.3 | 128.54 | 26.63 |
Cash Growth | -34.73% | -43.90% | -25.78% | 95.51% | 382.76% | - |
Other Receivables | - | - | 2.25 | - | - | - |
Receivables | - | - | 2.25 | - | - | - |
Prepaid Expenses | 4.46 | 5.78 | 4.04 | 4.06 | 1.43 | 1.12 |
Other Current Assets | 1.4 | 1.16 | 0.94 | - | - | - |
Total Current Assets | 85.33 | 111.58 | 193.75 | 255.36 | 129.96 | 27.74 |
Property, Plant & Equipment | 50.38 | 53.26 | 62.7 | 54.71 | 17.19 | 9.58 |
Long-Term Investments | - | - | 17.7 | - | - | - |
Other Long-Term Assets | 4.87 | 5.68 | 4.79 | 4.13 | 1.01 | 0.68 |
Total Assets | 140.58 | 170.52 | 278.95 | 314.19 | 148.16 | 38 |
Accounts Payable | 5.84 | 5.63 | 9.58 | 10.72 | 1.02 | 0.6 |
Accrued Expenses | 6.69 | 12.21 | 10 | 6.03 | 2.81 | 1.59 |
Current Portion of Leases | 3.01 | 4.32 | 4.01 | 1.99 | - | - |
Other Current Liabilities | 0.44 | 0.57 | 0.67 | 3.03 | 1.22 | 1.94 |
Total Current Liabilities | 16.18 | 22.73 | 24.25 | 21.77 | 5.04 | 4.12 |
Long-Term Leases | 11.53 | 8.11 | 11.09 | 13.71 | - | - |
Other Long-Term Liabilities | 0.28 | 0.25 | 0.23 | 0.18 | 3.68 | 4.58 |
Total Liabilities | 27.98 | 31.09 | 35.57 | 35.66 | 8.72 | 8.7 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | - | 0 |
Additional Paid-In Capital | 603.09 | 542.81 | 522.95 | 434.2 | 1.58 | 0.76 |
Retained Earnings | -490.58 | -403.28 | -279.2 | -155.53 | -82.81 | -44.42 |
Comprehensive Income & Other | 0.08 | -0.11 | -0.38 | -0.14 | -0.09 | -0.09 |
Total Common Equity | 112.6 | 139.42 | 243.38 | 278.53 | -81.32 | -43.74 |
Shareholders' Equity | 112.6 | 139.42 | 243.38 | 278.53 | 139.44 | 29.3 |
Total Liabilities & Equity | 140.58 | 170.52 | 278.95 | 314.19 | 148.16 | 38 |
Total Debt | 14.54 | 12.42 | 15.1 | 15.7 | - | - |
Net Cash (Debt) | 64.93 | 92.22 | 189.13 | 235.6 | 128.54 | 26.63 |
Net Cash Growth | -44.06% | -51.24% | -19.72% | 83.30% | 382.76% | - |
Net Cash Per Share | 0.79 | 1.25 | 4.22 | 13.29 | 132.23 | 35.23 |
Filing Date Shares Outstanding | 79.22 | 78.52 | 66.87 | 41.29 | 1.21 | 0.76 |
Total Common Shares Outstanding | 79.22 | 68.33 | 66.86 | 41.29 | 1.21 | 0.76 |
Working Capital | 69.15 | 88.85 | 169.51 | 233.58 | 124.92 | 23.62 |
Book Value Per Share | 1.42 | 2.04 | 3.64 | 6.75 | -67.18 | -57.87 |
Tangible Book Value | 112.6 | 139.42 | 243.38 | 278.53 | -81.32 | -43.74 |
Tangible Book Value Per Share | 1.42 | 2.04 | 3.64 | 6.75 | -67.18 | -57.87 |
Machinery | 40.56 | 40.28 | 39.98 | 12.64 | 8.97 | 6.6 |
Construction In Progress | 2.15 | 1.73 | 3.13 | 32.56 | 7.68 | - |
Leasehold Improvements | 25.73 | 25.61 | 23.61 | 7.24 | 7.24 | 7.21 |
Source: S&P Capital IQ. Standard template. Financial Sources.